title: [Pathogenetic treatment of multiple sclerosis: the present and the future].
abstract: Treatment of multiple sclerosis (MS) remains one of the most serious problems of modern medicine though a significant progress in understanding of disease pathogenesis has been achieved over the last years. Currently there are the ways of modifying the disease course that improve the remote prognosis. In this review, we present results of studies of drugs modifying the MS course which have been approved for MS treatment and those that are in the stage of clinical trials and expected to enlarge possibilities of MS treatment.
authors.forename: A N
authors.initials: AN
authors.lastname: Boĭko
authors.forename: I D
authors.initials: ID
authors.lastname: Stoliarov
authors.forename: T V
authors.initials: TV
authors.lastname: Sidorenko
authors.forename: O V
authors.initials: OV
authors.lastname: Kulakova
authors.forename: E V
authors.initials: EV
authors.lastname: Kol'iak
authors.forename: A M
authors.initials: AM
authors.lastname: Petrov
authors.forename: A G
authors.initials: AG
authors.lastname: Il'ves
authors.forename: I G
authors.initials: IG
authors.lastname: Nikiforova
authors.forename: O O
authors.initials: OO
authors.lastname: Favorova
authors.forename: E I
authors.initials: EI
authors.lastname: Gusev
mesh_terms: D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000276:immunology*; D016896:Treatment Outcome
chemical_list: D007155:Immunologic Factors